Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
  1. 4 Grant or award Chief Commercial Officer acquired 30,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale SVP, Finance and CFO sold 3,928 shares at $39.68 ($155,863)
  4. 4 Open-market buy Chief Executive Officer bought 27,800 shares at an average $35.57 ($988,882)
  5. 4 Exercise or conversion Director acquired 24,000 shares (option exercise)
  6. 4 Shares withheld for taxes SVP, China Operations gave up 3,038 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, Finance and CFO gave up 2,156 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 3,292 shares (to pay taxes)
  9. 4 Shares withheld for taxes SVP, Clinical Dev, Drug Safety gave up 2,728 shares (to pay taxes)
  10. 4 Grant or award Director acquired 4,700 shares (grant or award)
  11. 4 Grant or award Director acquired 4,700 shares (grant or award)
  12. 4 Grant or award Director acquired 4,700 shares (grant or award)
  13. 4 Grant or award Director acquired 4,700 shares (grant or award)
  14. 4 Grant or award Director acquired 4,700 shares (grant or award)
  15. 4 Grant or award Director acquired 4,700 shares (grant or award)
  16. 4 Grant or award Director acquired 4,700 shares (grant or award)
  17. 4 Grant or award Director acquired 4,700 shares (grant or award)
  18. 4 Grant or award Director acquired 4,700 shares (grant or award)
  19. 4 Grant or award Director acquired 4,700 shares (grant or award)
  20. 4 Open-market sale Director sold 18,000 shares at $23.17 ($417,074)

Page 13 of 38 · 760 filings